Advanced Filters
noise
Found 1,651 clinical trials
N Ngiap Chuan Tan, MMed

Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring

Background: Diabetes significantly raises the likelihood of complications, thereby increasing the risk of diabetes-related mortality, particularly due to vascular complications. It is vital to address this rising trend of mortality, by enhancing awareness of diabetes complications to improve risk perception and ultimately reduce mortality rates. Managing diabetes effectively requires interventions …

36 - 65 years of age All Phase N/A
k kanmani kumaran, MD

Effect of Meal Replacement Therapy on Glucose Control and Metabolic Parameters in Patients With Uncontrolled Diabetes

To evaluate the effect of meal replacement therapy on glucose control and other metabolic parameters in patients with uncontrolled type 2 diabetes. Methodology This is an open-label, prospective, randomized control trial study. Study duration. August 2023 - March 2026. Study location. This study will be conducted at the Klinik Rawatan …

30 - 65 years of age All Phase N/A
S Staff Research Associate

HOPE Intervention for Fitness

We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).

18 years of age All Phase N/A
I Ivana Kolčić, Professor

Remission of Type 2 Diabetes With Lifestyle Intervention

The goal of this clinical trial is to achieve diabetes type 2 (DM2) remission using intensive lifestyle intervention. The main questions it aims to answer are: Does intensive lifestyle intervention (including Mediterranean diet with a caloric deficit, daily physical activity, increase in stress resilience and group support) lead to DM2 …

20 - 69 years of age All Phase N/A
M Mostafa M Bahaa, PhD

Doxycycline in Type II Diabetes

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, weight loss, and cardio-metabolic complications. T2DM develops due to the progression of insulin resistance (IR), impairment of insulin insensitivity, and failure of the pancreatic β-cells to release sufficient amount of insulin in response to glucose burden

40 - 60 years of age All Phase 1/2
R Regina Moreno, MD

Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)

This is an open, randomized, controlled trial to determine the impact of an integrative group program on metabolic control and wellbeing perception of patients with T2DM. The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions …

18 - 80 years of age All Phase N/A
K Kalie Tommerdahl

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

High-resistance, short-duration inspiratory muscle strength training (IMST) is a novel lifestyle intervention involving 30 inhalations against a resistive load which requires only ~5 min/day and is thus ideal for youth with T2D (Y-T2D). Investigators seek to 1: assess changes in casual and 24-hr SBP, endothelial function, and arterial stiffness after …

14 - 40 years of age All Phase N/A
E Elena Tortato, MD

Connected Care for Type 2 Diabetes Self-Management

The primary objective of this Randomized Clinical Trial is to improve the self-management (SM) competencies of patients affected by Type 2 Diabetes Mellitus (T2DM) living in the Marche region (Italy) through the support of a mobile health (m-health) solution personalised by the diabetologist and integrated with the Electronic Patient Record …

18 years of age All Phase N/A
S Sayed Murtaza Sadat Hofiani, MPH

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.

20 years of age All Phase N/A
A Anne-Marie Aas, Phd

DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes

This registration covers a pilot for a 3-armed parallel-group randomized controlled trial (RCT) that will evaluate the efficacy of DiaMester, a Norwegian e-health programme designed to improve self-management and induce clinically meaningful weight loss, and thereby potential remission in adults with type 2 diabetes (T2D).

18 years of age All Phase N/A

Simplify language using AI